Pliant Therapeutics's total assets for Q3 2024 were $445.67M, a decrease of -7.87% from the previous quarter. PLRX total liabilities were $99.84M for the fiscal quarter, a 9.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.